Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -162,857 | -128,647 | -77,540 | -40,610 | -146,398 |
| Depreciation Amortization | 96,998 | 83,098 | 44,803 | 6,766 | 30,894 |
| Accounts receivable | N/A | -54,258 | N/A | -18,576 | N/A |
| Accounts payable and accrued liabilities | 10,635 | 4,018 | -130 | -4,878 | -15,104 |
| Other Working Capital | -25,843 | -40,744 | -35,015 | -26,980 | 13,225 |
| Other Operating Activity | -27,489 | 35,977 | -3,792 | 42,570 | 73,506 |
| Operating Cash Flow | $-108,556 | $-100,556 | $-71,674 | $-41,708 | $-43,877 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 172,796 | 105,784 | 102,558 | 51,267 | -110,573 |
| PPE Investments | -78,396 | -62,766 | -44,250 | -24,140 | -76,947 |
| Purchase Of Investment | -8,699 | 13,538 | 3,950 | -4,385 | -58,899 |
| Other Investing Activity | 35,708 | 29,150 | 19,750 | 7,168 | 25,311 |
| Investing Cash Flow | $121,409 | $85,706 | $82,008 | $29,910 | $-221,108 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 13,498 | N/A | 5,850 | N/A | 11,590 |
| Common Stock Issued | N/A | 9,179 | N/A | 3,016 | N/A |
| Other Financing Activity | -729 | -552 | -368 | -185 | -1,234 |
| Financing Cash Flow | $12,769 | $8,627 | $5,482 | $2,831 | $10,356 |
| Exchange Rate Effect | -2,617 | -457 | -824 | -781 | 589 |
| Beginning Cash Position | 160,610 | 160,610 | 160,610 | 160,610 | 414,650 |
| End Cash Position | 183,615 | 153,930 | 175,602 | 150,862 | 160,610 |
| Net Cash Flow | $23,005 | $-6,680 | $14,992 | $-9,748 | $-254,040 |
| Free Cash Flow | |||||
| Operating Cash Flow | -108,556 | -100,556 | -71,674 | -41,708 | -43,877 |
| Capital Expenditure | -78,396 | -62,766 | -44,250 | -24,140 | -76,947 |
| Free Cash Flow | -186,952 | -163,322 | -115,924 | -65,848 | -120,824 |